Detection of Parkinson's Disease through the Peptoid Recognizing α-Synuclein in Serum

ACS Chem Neurosci. 2019 Mar 20;10(3):1204-1208. doi: 10.1021/acschemneuro.8b00540. Epub 2019 Jan 29.

Abstract

Parkinson's disease (PD) is a severe neurodegenerative disease and there is great need for developing a biochemical detection method to precisely diagnose it. Alpha-synuclein (α-syn) participates in the main pathology of PD and serves as an important biomarker of PD. Here, we identified peptoid ASBP-7 that had high affinity and specificity to α-syn by screening a peptoid library using the high-throughput surface plasmon resonance imaging method. We confirmed that ASBP-7 could significantly distinguish PD sera from the normal ones through identifying α-syn in the serum. We also demonstrated the high sensitivity of this system in detecting PD serum. This work provides a method for the blood-based, label-free, high-throughput analysis of PD serum, and holds great potential for the early diagnosis and dynamic monitoring of PD.

Keywords: Parkinson’s disease; blood-based detection; peptoid; surface plasmon resonance imaging; α-synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Blood Chemical Analysis / methods
  • Early Diagnosis
  • Female
  • High-Throughput Screening Assays / methods
  • Humans
  • Male
  • Microarray Analysis
  • Molecular Docking Simulation
  • Parkinson Disease / blood*
  • Peptoids
  • Surface Plasmon Resonance
  • alpha-Synuclein / blood*

Substances

  • Biomarkers
  • Peptoids
  • SNCA protein, human
  • alpha-Synuclein